Maxillomandibular advancement in edentulous patients as a treatment option for obstructive sleep apnea: report of two cases and a proposed treatment protocol.
Heliyon 2020;
6:e03873. [PMID:
32373751 PMCID:
PMC7193315 DOI:
10.1016/j.heliyon.2020.e03873]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2019] [Revised: 09/05/2019] [Accepted: 04/23/2020] [Indexed: 10/28/2022] Open
Abstract
Obstructive sleep apnea (OSA) is a common disease that often causes debilitating symptoms. In its most severe form, OSA increases the risk of cardiovascular disease and mortality. OSA is characterized by repeated episodes of pharyngeal collapse leading to airway obstruction. The treatment options available in severe cases are limited to continuous positive airway pressure ventilation and maxillomandibular advancement (MMA). OSA is particularly difficult to treat successfully in edentulous patients. Two cases are presented here to illustrate use of MMA in edentulous patients with OSA. Our learning points based on these cases are shared, and a treatment and follow-up protocol is proposed for this specific patient group.
Collapse